Benet lz
Benet lz
Verified email at ucsf.edu
Title
Cited by
Cited by
Year
Goodman and Gilman's the pharmacological basis of therapeutics
LS Goodman
McGraw-Hill, 1996
166441996
Membrane transporters in drug development
KM Giacomini, SM Huang, DJ Tweedie, LZ Benet, KLR Brouwer, X Chu, ...
Nature reviews Drug discovery 9 (3), 215, 2010
27632010
Giving full measure to countermeasures: addressing problems in the DoD program to develop medical countermeasures against biological warfare agents
National Research Council
National Academies Press, 2004
2120*2004
Encyclopedia of Pharmaceutical Technology: Volume 6
J Swarbrick
Crc Press, 2013
16062013
Predicting drug disposition via application of BCS: transport/absorption/elimination interplay and development of a biopharmaceutics drug disposition classification system
CY Wu, LZ Benet
Pharmaceutical research 22 (1), 11-23, 2005
14182005
Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P‐glycoprotein: implications for drug delivery and activity in cancer chemotherapy
VJ Wacher, CY Wu, LZ Benet
Molecular carcinogenesis 13 (3), 129-134, 1995
10361995
Pharmacokinetics: the dynamics of drug absorption, distribution, metabolism, and elimination
LZ Benet, D Kroetz, L Sheiner, J Hardman, L Limbird
Goodman and Gilman’s the pharmacological basis of therapeutics 3, e27, 1996
9571996
Noncompartmental determination of the steady‐state volume of distribution
LZ Benet, RL Galeazzi
Journal of pharmaceutical sciences 68 (8), 1071-1074, 1979
9081979
Clearance concepts in pharmacokinetics
M Rowland, LZ Benet, GG Graham
Journal of pharmacokinetics and biopharmaceutics 1 (2), 123-136, 1973
8391973
Hearth and home: Images of women in the mass media
G Tuchman, AK Daniels, J Benet
Oxford University Press, 1978
8331978
Role of intestinal P‐glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine
KS Lown, RR Mayo, AB Leichtman, H Hsiao, DK Turgeon, ...
Clinical pharmacology & therapeutics 62 (3), 248-260, 1997
8261997
Changes in plasma protein binding have little clinical relevance
LZ Benet, BA Hoener
Clinical Pharmacology & Therapeutics 71 (3), 115-121, 2002
7842002
Design and otpimization of dosage regimen: Pharmacokinetic data
LI Benet
The pharmacological basis of therapeutics, 1991
733*1991
The gut as a barrier to drug absorption
Y Zhang, LZ Benet
Clinical pharmacokinetics 40 (3), 159-168, 2001
6312001
Gender effects in pharmacokinetics and pharmacodynamics
RZ Harris, LZ Benet, JB Schwartz
Drugs 50 (2), 222-239, 1995
5981995
Role of P‐glycoprotein and cytochrome P450 3A in limiting oral absorption of peptides and peptidomimetics
VJ Wacher, JA Silverman, Y Zhang, LZ Benet
Journal of pharmaceutical sciences 87 (11), 1322-1330, 1998
5591998
BDDCS applied to over 900 drugs
LZ Benet, F Broccatelli, TI Oprea
The AAPS journal 13 (4), 519-547, 2011
5112011
Acyl glucuronides revisited: is the glucuronidation proces a toxification as well as a detoxification mechanism?
HS Langguth, LZ Benet
Drug metabolism reviews 24 (1), 5-47, 1992
5061992
Predicting drug disposition, absorption/elimination/transporter interplay and the role of food on drug absorption
JM Custodio, CY Wu, LZ Benet
Advanced drug delivery reviews 60 (6), 717-733, 2008
4482008
Bioavailability of cyclosporine with concomitant rifampin administration is markedly less than predicted by hepatic enzyme induction
MF Hebert, JP Roberts, T Prueksaritanont, LZ Benet
Clinical Pharmacology & Therapeutics 52 (5), 453-457, 1992
4341992
The system can't perform the operation now. Try again later.
Articles 1–20